1. Home
  2. CVAC vs HPP Comparison

CVAC vs HPP Comparison

Compare CVAC & HPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • HPP
  • Stock Information
  • Founded
  • CVAC 2000
  • HPP 2009
  • Country
  • CVAC Germany
  • HPP United States
  • Employees
  • CVAC N/A
  • HPP N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • HPP Real Estate
  • Sector
  • CVAC Health Care
  • HPP Finance
  • Exchange
  • CVAC Nasdaq
  • HPP Nasdaq
  • Market Cap
  • CVAC 637.1M
  • HPP 660.6M
  • IPO Year
  • CVAC 2020
  • HPP 2010
  • Fundamental
  • Price
  • CVAC $2.54
  • HPP $3.69
  • Analyst Decision
  • CVAC Hold
  • HPP Hold
  • Analyst Count
  • CVAC 3
  • HPP 11
  • Target Price
  • CVAC $10.00
  • HPP $5.95
  • AVG Volume (30 Days)
  • CVAC 540.3K
  • HPP 2.4M
  • Earning Date
  • CVAC 11-12-2024
  • HPP 11-12-2024
  • Dividend Yield
  • CVAC N/A
  • HPP 5.43%
  • EPS Growth
  • CVAC N/A
  • HPP N/A
  • EPS
  • CVAC N/A
  • HPP N/A
  • Revenue
  • CVAC $70,565,734.00
  • HPP $847,713,000.00
  • Revenue This Year
  • CVAC $123.97
  • HPP N/A
  • Revenue Next Year
  • CVAC N/A
  • HPP $2.73
  • P/E Ratio
  • CVAC N/A
  • HPP N/A
  • Revenue Growth
  • CVAC 75.11
  • HPP N/A
  • 52 Week Low
  • CVAC $2.22
  • HPP $3.66
  • 52 Week High
  • CVAC $6.30
  • HPP $9.86
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 34.97
  • HPP 32.52
  • Support Level
  • CVAC $2.73
  • HPP $4.04
  • Resistance Level
  • CVAC $2.97
  • HPP $4.51
  • Average True Range (ATR)
  • CVAC 0.18
  • HPP 0.27
  • MACD
  • CVAC -0.01
  • HPP -0.05
  • Stochastic Oscillator
  • CVAC 7.55
  • HPP 2.97

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About HPP Hudson Pacific Properties Inc.

Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.

Share on Social Networks: